Detalhe da pesquisa
1.
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia.
Haematologica
; 107(1): 49-57, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299233
2.
Multidisciplinary Network ActiveOncoKids guidelines for providing movement and exercise in pediatric oncology: Consensus-based recommendations.
Pediatr Blood Cancer
; 69(11): e29953, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073842
3.
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study.
Ther Drug Monit
; 42(3): 435-444, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022785
4.
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.
Haematologica
; 104(9): 1812-1821, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705097
5.
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial.
Ther Drug Monit
; 40(1): 93-102, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29210976
6.
One in Four Questioned Children Faces Problems Regarding Reintegration Into Physical Education at School After Treatment for Pediatric Cancer.
Pediatr Blood Cancer
; 63(4): 737-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681662
7.
Motor Performance After Treatment for Pediatric Bone Tumors.
J Pediatr Hematol Oncol
; 37(7): 509-14, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26207777
8.
Motor performance in children and adolescents with cancer at the end of acute treatment phase.
Eur J Pediatr
; 174(6): 791-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428233
9.
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
Haematologica
; 99(11): 1716-21, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25150254
10.
Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase.
Ther Drug Monit
; 36(4): 549-52, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342897
11.
Comparison of self-reported physical activity in children and adolescents before and during cancer treatment.
Pediatr Blood Cancer
; 61(6): 1023-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24357259
12.
Experience of barriers and motivations for physical activities and exercise during treatment of pediatric patients with cancer.
Pediatr Blood Cancer
; 61(9): 1632-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24753116
13.
Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients.
Pediatr Blood Cancer
; 61(2): 306-11, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24174393
14.
Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosing.
Eur J Clin Pharmacol
; 70(7): 839-47, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24810613
15.
Sports in pediatric oncology: the role(s) of physical activity for children with cancer.
J Pediatr Hematol Oncol
; 36(2): 85-90, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390449
16.
Predictive performance of a physiologically based pharmacokinetic model of busulfan in children.
Pediatr Hematol Oncol
; 31(8): 731-42, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25007236
17.
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
J Clin Oncol
; 42(8): 915-926, 2024 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096462
18.
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
Antimicrob Agents Chemother
; 57(4): 1664-71, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335740
19.
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
Blood
; 118(22): 5774-82, 2011 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21940824
20.
No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
Pediatr Blood Cancer
; 60(2): 258-61, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22961784